✦ LIBER ✦

075 Identification of patients at risk for premature discontinuation of oral antiplatelet therapy after elective percutaneous coronary intervention

✍ Scribed by Guillaume Cayla; Jean Philippe Collet; Johanne Silvain; Laurent Schmutz; Bertrand Ledermann; Jean-Christophe Macia; Richard Gervasoni; Luc Cornillet; Florence Leclercq; Patrick Messner-Pellenc

Book ID: 119641358
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 3
Category: Article
ISSN: 1878-6480
DOI: 10.1016/s1878-6480(11)70077-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identifying Patients at Risk for Prematu

Identifying Patients at Risk for Premature Discontinuation of Thienopyridine After Coronary Stent Implantation

✍ Alexandre S. Quadros; Dulce I. Welter; Fernanda O. Camozzatto; Áurea Chaves; Raj 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Dual Antiplatelet Therapy After Percutan

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral Anticoagulation

✍ Renata Rogacka; Alaide Chieffo; Iassen Michev; Flavio Airoldi; Azeem Latib; John 📂 Article 📅 2008 🏛 American College of Cardiology 🌐 English ⚖ 117 KB

Risk of Major Bleeding with Concomitant

Risk of Major Bleeding with Concomitant Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients Receiving Long-Term Warfarin Therapy

✍ Dr. Deborah DeEugenio; Mr. Louis Kolman; Dr. Matthew DeCaro; Ms. Jocelyn Andrel; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Prevention of renal function worsening a

Prevention of renal function worsening after percutaneous coronary interventions by hemofiltration in patients at high risk for contrast nephropathy

✍ Giancarlo Marenzi; Gianfranco Lauri; Emilio Assanelli; Marco Grazi; Jeness Campo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Bleeding risk associated with 1 year of

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

✍ Herbert D. Aronow; Steven R. Steinhubl; Danielle M. Brennan; Peter B. Berger; Er 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A Therapeutic Window for Platelet Reacti

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty–Platelet Reactivity for Outcome Validation Effort) Study

✍ Fabio Mangiacapra; Giuseppe Patti; Emanuele Barbato; Aaron J. Peace; Elisabetta 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 954 KB